Stay updated on Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.

Latest updates to the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label 'Revision: v3.4.2' was added, and the funding-status notice and 'Revision: v3.4.1' were removed. These are administrative changes that do not alter study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide funding status notice and updated references to the NIH Clinical Center's operating status, including links to opm.gov. Updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary is now shown on the page, and there are minor capitalization updates to QC labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section added with California as a location; California Locations subsection removed. HHS Vulnerability Disclosure link removed; page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange Detected- Revision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.